Stephen Yoo
- Rheumatology top 1%
- Immunology top 5%
- interferon and immune responses 2
- Radiation top 5%
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- PARP inhibition in cancer therapy 4
-
- Retinal Development and Disorders 3
- Glycosylation and Glycoproteins Research 2
- DNA Repair Mechanisms 2
-
- Virus-based gene therapy research 2
-
- Gastrointestinal disorders and treatments 2
- Co-authors
- Jeffrey C. WangKenneth KalunianVictoria P. WerthJoan T. MerrillRichard FurieJörn DrappaPhilip Z. BrohawnMunther A. Khamashta
- Cited by
- RheumatologyImmunologyRadiation
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Stephen Yoo
35 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Rheumatology 604
- Immunology 612
- Radiation 150
- Radiology, Nuclear Medicine and Imaging 385
- Oncology 454
Countries citing papers authored by Stephen Yoo
This map shows the geographic impact of Stephen Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Yoo more than expected).
Fields of papers citing papers by Stephen Yoo
This network shows the impact of papers produced by Stephen Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Yoo. The network helps show where Stephen Yoo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen Yoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2020 | 133 | |
| 3 | 2020 | 67 | |
| 4 | Safety of the Subretinal Delivery of RGX-314 AAV8-anti-VEGF Fab Gene Therapy in NHP: Retinal Structure Over One Year | 2018 | 2 |
| 5 | Subretinal delivery of RGX-314 AAV8-anti-VEGF Fab gene therapy in NHP | 2017 | 1 |
| 6 | 2017 | 40 | |
| 7 | Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosusbreakdown → | 2016 | 618 |
| 8 | 2015 | 1 | |
| 9 | 2014 | 31 | |
| 10 | 2014 | 146 | |
| 11 | 2012 | 64 | |
| 12 | 2011 | 42 | |
| 13 | 2011 | 20 | |
| 14 | 2010 | 4 | |
| 15 | 2009 | 81 | |
| 16 | 2006 | 6 | |
| 17 | 2004 | 34 | |
| 18 | 2003 | 144 | |
| 19 | 2001 | 25 | |
| 20 | 1999 | 97 |
About Stephen Yoo
Stephen Yoo is a scholar working on Developmental Biology, Oncology, Gastroenterology, Radiology, Nuclear Medicine and Imaging and Ophthalmology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), PARP inhibition in cancer therapy (4 papers), Retinal Development and Disorders (3 papers), Glycosylation and Glycoproteins Research (2 papers), interferon and immune responses (2 papers), Virus-based gene therapy research (2 papers), DNA Repair Mechanisms (2 papers) and Gastrointestinal disorders and treatments (2 papers). The work is most often cited by research in Rheumatology (604 citations), Immunology (612 citations), Radiation (150 citations), Radiology, Nuclear Medicine and Imaging (385 citations) and Oncology (454 citations). Stephen Yoo has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Jeffrey C. Wang, Kenneth Kalunian, Victoria P. Werth, Joan T. Merrill, Richard Furie, Jörn Drappa, Philip Z. Brohawn, Munther A. Khamashta, Liangwei Wang and Gabor G. Illei. Their work appears in journals such as Cancer Research, The American Surgeon, Radiation Research, Dermatologic Surgery and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.